Literature DB >> 12072935

Anthrax in adults and children: a review of 132 cases in Turkey.

A Kaya1, M A Tasyaran, S Erol, Z Ozkurt, B Ozkan.   

Abstract

In this retrospective study, 132 cases of anthrax observed in a Turkish hospital over a 14-year period (October 1986 to October 2000) were evaluated with respect to clinical features, therapy, and outcome. The results show that anthrax is a disease of significance in the Eastern Anatolian region of Turkey. Preventive measures such as education of the population and vaccination of animals against anthrax would reduce the incidence of the disease.

Entities:  

Mesh:

Year:  2002        PMID: 12072935     DOI: 10.1007/s10096-002-0704-6

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

1.  Phase 1 study of a recombinant mutant protective antigen of Bacillus anthracis.

Authors:  Joseph A Bellanti; Feng-Ying C Lin; Chiayung Chu; Joseph Shiloach; Stephen H Leppla; German A Benavides; Arthur Karpas; Mahtab Moayeri; Chunyan Guo; John B Robbins; Rachel Schneerson
Journal:  Clin Vaccine Immunol       Date:  2011-12-21

2.  Additional conjugation methods and immunogenicity of Bacillus anthracis poly-gamma-D-glutamic acid-protein conjugates.

Authors:  Joanna Kubler-Kielb; Teh-Yung Liu; Christopher Mocca; Fathy Majadly; John B Robbins; Rachel Schneerson
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

3.  Molecular epidemiology of the Bacillus anthracis isolates collected throughout Turkey from 1983 to 2011.

Authors:  R Durmaz; M Doganay; M Sahin; D Percin; M K Karahocagil; U Kayabas; B Otlu; A Karagoz; F Buyuk; O Celebi; Z Ozturk; M Ertek
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-11       Impact factor: 3.267

4.  Anthrax in eastern Turkey, 1992-2004.

Authors:  Zülal Ozkurt; Mehmet Parlak; Rustu Tastan; Ufuk Dinler; Yavuz S Saglam; Serhat F Ozyurek
Journal:  Emerg Infect Dis       Date:  2005-12       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.